Can Jersey City Be A Cure For What Ails Pharma?
Executive Summary
One of the highlights of the Pharmaceutical Research & Manufacturers of America's annual meeting in Jersey City, N.J., was a fill-in-the-blank exercise.
You may also be interested in...
PhRMA CEO: Ubl Pick Brings User Fee, Reimbursement Expertise
Steve Ubl has led AdvaMed for 10 years, raising profile of device industry on Capitol Hill and executing well-regarded public relations campaign of the kind the drug industry might need as it enters political maelstrom on pricing.
PhRMA CEO: Ubl Pick Would Bring User Fee, Reimbursement Expertise
Steve Ubl has led AdvaMed for 10 years, raising profile of device industry on Capitol Hill, but also developing reputation of his own as a policy wonk.
Rx Reimbursement Model Must Change For Pharma To Flourish, Castellani Says
The pharmaceutical industry must work to change two "insidious" reimbursement paradigms if it hopes to be able to continue to develop additional medications, PhRMA CEO John Castellani said in his first major policy address.